Randomized Phase II Study of Bortezomib, Lenalidomide, and Dexamethasone (VRD) Versus Lenalidomide and Dexamethasone (RD) in Elderly Patients with Newly Diagnosed Multiple Myeloma (KMM1910).
Saved in:
| Title: | Randomized Phase II Study of Bortezomib, Lenalidomide, and Dexamethasone (VRD) Versus Lenalidomide and Dexamethasone (RD) in Elderly Patients with Newly Diagnosed Multiple Myeloma (KMM1910). |
|---|---|
| Authors: | Yi JH; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Yoon SE; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Lee JH; Division of Hematology-Oncology, Department of Internal Medicine, Dong-A University College of Medicine, Busan, Korea., Bang SM; Division of Hematology-Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea., Lee MW; Division of Hematology-Oncology, Department of Internal Medicine, Chungnam National University Hospital, Daejeon, Korea., Moon JH; Division of Hematology-Oncology, Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Korea., Lee JJ; Division of Hematology-Oncology, Department of Internal Medicine, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Korea., Eom HS; Center for Hematologic Malignancy, National Cancer Center, Goyang, Korea., Min CK; Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea., Do YR; Division of Hematology-Oncology, Department of Internal Medicine, Dongsan Medical Center, Keimyung University, Daegu, Korea., Lim S; Division of Hematology-Oncology, Department of Internal Medicine, Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea., Shin HJ; Division of Hematology-Oncology, Department of Internal Medicine, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea., Lee JH; Division of Hematology-Oncology, Department of Internal Medicine, Gachon University Medical College, Gachon University Gil Medical Center, Incheon, Korea., Kim HJ; Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang, Korea., Yoon SS; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea., Kim K; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. kihyunk@skku.edu. |
| Source: | Cancer research and treatment [Cancer Res Treat] 2026 May 29. Date of Electronic Publication: 2026 May 29. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Korean Cancer Association Country of Publication: Korea (South) NLM ID: 101155137 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2005-9256 (Electronic) Linking ISSN: 15982998 NLM ISO Abbreviation: Cancer Res Treat Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
